Your browser doesn't support javascript.
loading
Media framing xylazine as a "zombie drug" is amplifying stigma onto people who use drugs.
Bowles, Jeanette M; Copulsky, Elizabeth C; Reed, Megan K.
Affiliation
  • Bowles JM; British Columbia Centre on Substance Use: Vancouver, BC, Canada; University of British Columbia Department of Medicine: Vancouver, BC, Canada. Electronic address: jeanette.bowles@bccsu.ubc.ca.
  • Copulsky EC; University of Illinois at Chicago School of Public Health: Chicago, IL, USA.
  • Reed MK; Department of Emergency Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA; Center for Connected Care, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA; College of Population Health, Thomas Jefferson University, Philadelphia, PA, USA.
Int J Drug Policy ; 125: 104338, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38364357
ABSTRACT
Amid increasing efforts to understand xylazine-associated harms, examining the potentially catastrophic role of stigma resulting from media outlets framing xylazine as the "zombie drug" is imperative. Zombies are cinematically depicted as soulless, dangerous, and required to be killed off entirely for public safety, making the "zombie" analogy especially grave amid the fatal overdose crisis. Xylazine is called the "zombie drug" due to its heavy sedative effect and associated-severely infected skin ulcers. We surmise that wide-scale media framing of xylazine as the "zombie drug" has increased stigmas onto people who use drugs as their likening to zombies reifies subhuman status. The present commentary highlights many media headlines and quotes that use "zombie" terminology when writing about xylazine, and examine how this expansive media framing amplifies stigmas. Xylazine's proliferation in the illicit drug market will likely increase infected ulcers needing medical attention. People who use drugs are often reluctant to seek medical care due to experiences of medically-institutionalized stigma. Based on the media's extensive depiction of xylazine as the "zombie drug," it is plausible that medical practitioners have been exposed to this stigmatizing framing, which could unknowingly detrimentally impact provision of medical care. Strategies to offset harms of xylazine-associated stigmas are proposed, including that medical practitioners undergo evidence-based training to reduce stigmatizing responses to severe xylazine-associated ulcers as any indication of enacted stigma can be internalized by the person seeking treatment, which in turn can perpetuate harms like sepsis or overdose. Author ethnographic observations of xylazine presence are included, which encompass three distinct urban settings that span North America. Finally, we suggest approaches media outlets could adopt to reflect on how referring to xylazine as the "zombie" drug amplifies stigmas onto people already surviving under structural conditions heightening physical and mental trauma, and use language instead that could aid in lessening these harms.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Xylazine / Drug Overdose Limits: Humans Language: En Journal: Int J Drug Policy Journal subject: SAUDE PUBLICA / TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Xylazine / Drug Overdose Limits: Humans Language: En Journal: Int J Drug Policy Journal subject: SAUDE PUBLICA / TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2024 Document type: Article
...